Fortis Healthcare Ltd

Fortis Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Fortis Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive category, reflecting evolving market perceptions. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, comparing them with historical trends and peer benchmarks to assess the stock’s price attractiveness.

Fortis Healthcare Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend across key indicators. This transition, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, suggests a cautiously optimistic outlook for the hospital sector mid-cap stock amid mixed market conditions.

The 50-day moving average has crossed above the 200-day moving average for Fortis Healthcare Ltd, signalling a golden cross on 15 Jun 2026. Yet, the stock declined 1.04% on the day this crossover occurred, while monthly momentum indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the technical and fundamental backdrop to assess the reliability of this widely watched event.

Fortis Healthcare Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its technical outlook and valuation metrics despite flat recent financial performance. The mid-cap hospital sector stock’s improved technical indicators and sustained long-term returns have prompted a reassessment, although valuation concerns remain elevated.

Fortis Healthcare Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors in the hospital sector mid-cap stock.

Fortis Healthcare Ltd has witnessed a significant surge in open interest in its derivatives segment, coinciding with a strong upward price momentum. The stock has outperformed its sector and broader indices, reflecting increased market participation and evolving positioning among traders and investors.

Fortis Healthcare Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock’s recent outperformance against its sector and the broader Sensex, coupled with a sustained rally, has attracted fresh speculative interest, raising questions about the underlying directional bets and potential implications for the hospital sector mid-cap.

Fortis Healthcare Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock has outperformed its sector peers with a strong six-day rally, supported by rising volumes and improving technical indicators, despite a recent downgrade in its Mojo Grade to Sell.

Fortis Healthcare Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock’s recent outperformance against its sector and the broader market, coupled with a sustained rally, has attracted increased speculative interest, raising questions about potential directional bets and future price trajectories.

Fortis Healthcare Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock’s recent outperformance against its sector and the broader Sensex, combined with a sustained rally over six consecutive sessions, underscores a growing bullish sentiment despite a recent downgrade in its Mojo Grade to Sell.

On 8 Jun 2026, 5,516 call contracts on Fortis Healthcare Ltd changed hands at the Rs 1,000 strike price, with the stock closing just shy of that level at Rs 999.75. This synchrony between the options and cash markets highlights a focused directional stance ahead of the 30 Jun 2026 expiry.

Fortis Healthcare Ltd has seen a marked shift in its valuation parameters, moving from expensive to very expensive territory, despite delivering robust returns that have outpaced the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics, compares them with industry peers, and assesses the implications for investors navigating the hospital sector’s evolving landscape.

Fortis Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Fortis Healthcare Ltd, a mid-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day change of 0.06% and a current price of ₹930.10, the stock’s technical indicators present a complex picture, with bullish signals on weekly charts contrasting with mildly bearish monthly trends. This article analyses the recent technical developments, key momentum indicators, and the implications for investors amid a backdrop of strong long-term returns compared to the Sensex.

Fortis Healthcare Ltd, a mid-cap player in the hospital sector, has seen a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest decline in daily price and a downgrade in its Mojo Grade from Hold to Sell, the stock’s longer-term performance remains robust, outpacing the Sensex over multiple time horizons.

Fortis Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of early June 2026. Despite a recent downgrade in its technical grade from Sell to Hold, the stock exhibits a complex interplay of bullish and bearish signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors in the hospital sector.

Fortis Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a recalibration of the stock’s price attractiveness amid evolving market conditions and peer comparisons.